Is the suppression of CD36 a promising way for atherosclerosis therapy?

Wen, Shi-Yuan; Zhi, Xiaoyan; Liu, Hai-Xin; Wang, Xiaohui; Chen, Yan-Yan; Wang, Li

Wen, Shi-Yuan; Zhi, Xiaoyan; Liu, Hai-Xin; Wang, Xiaohui; Chen, Yan-Yan; Wang, Li.

Afiliação

Wen SY; College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Zhi X; College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Liu HX; School of Traditional Chinese Materia Medica, Shanxi University of Chinese Medicine, Taiyuan, China.
Wang X; College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
Chen YY; School of Medicine, Jiangsu University, Zhenjiang, China. Electronic address: yanyanchen@ujs.edu.cn.
Wang L; College of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China. Electronic address: mirror0117@126.com.

Biochem Pharmacol ; 219: 115965, 2024 01.

Article em En | MEDLINE | ID: mdl-38043719

Assuntos

Aterosclerose; Humanos; Aterosclerose/metabolismo; Células Espumosas/metabolismo; Regulação para Cima; Inflamação/metabolismo; Lipídeos; Lipoproteínas LDL/metabolismo

Palavras-chave

Atherosclerosis; CD36; Drug therapy; Lipid metabolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose Limite: Humans Idioma: En Revista: Biochem Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google